Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,615 | 633 | 99.6% |
| Education | $50.56 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $5,847 | 373 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,412 | 23 | $0 (2024) |
| Novo Nordisk Inc | $1,285 | 112 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $726.96 | 13 | $0 (2019) |
| GlaxoSmithKline, LLC. | $711.17 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $507.04 | 11 | $0 (2021) |
| Lilly USA, LLC | $449.33 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $435.31 | 7 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $391.62 | 5 | $0 (2018) |
| ABBVIE INC. | $323.73 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,052 | 58 | Janssen Pharmaceuticals, Inc ($353.06) |
| 2023 | $1,200 | 71 | Janssen Pharmaceuticals, Inc ($497.15) |
| 2022 | $1,182 | 89 | Janssen Pharmaceuticals, Inc ($845.14) |
| 2021 | $1,887 | 136 | Janssen Pharmaceuticals, Inc ($1,053) |
| 2020 | $1,169 | 62 | Janssen Pharmaceuticals, Inc ($655.82) |
| 2019 | $2,555 | 78 | Janssen Pharmaceuticals, Inc ($1,409) |
| 2018 | $2,639 | 84 | Janssen Pharmaceuticals, Inc ($744.03) |
| 2017 | $1,980 | 63 | AstraZeneca Pharmaceuticals LP ($406.97) |
All Payment Transactions
641 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 07/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,093 | 2,680 | $317,526 | $155,839 |
| 2022 | 13 | 1,016 | 2,772 | $292,335 | $143,234 |
| 2021 | 21 | 1,033 | 2,832 | $292,745 | $143,402 |
| 2020 | 16 | 903 | 2,745 | $247,787 | $116,971 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 474 | $114,708 | $48,907 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 181 | 181 | $51,585 | $27,680 | 53.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 1,200 | $29,000 | $21,779 | 75.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 283 | $54,619 | $21,280 | 39.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 162 | 166 | $18,592 | $11,927 | 64.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 174 | 178 | $9,078 | $6,460 | 71.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $9,095 | $4,491 | 49.4% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 14 | 14 | $4,690 | $3,378 | 72.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $5,250 | $2,713 | 51.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $4,620 | $2,706 | 58.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $8,680 | $2,464 | 28.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,377 | $979.83 | 71.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 36 | $2,340 | $468.18 | 20.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 29 | $2,668 | $360.72 | 13.5% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 12 | 12 | $1,224 | $245.52 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 432 | $104,494 | $44,257 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 184 | 184 | $52,440 | $28,274 | 53.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,380 | $33,350 | $23,280 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 296 | $57,128 | $22,418 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 152 | 152 | $17,024 | $10,418 | 61.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 177 | 178 | $9,078 | $6,418 | 70.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $5,280 | $3,121 | 59.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $4,125 | $2,136 | 51.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $1,326 | $939.89 | 70.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $1,219 | $722.58 | 59.3% |
About Dr. Yin-Yin Myint, M.D
Dr. Yin-Yin Myint, M.D is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184638645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yin-Yin Myint, M.D has received a total of $13,665 in payments from pharmaceutical and medical device companies, with $1,052 received in 2024. These payments were reported across 641 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($13,615).
As a Medicare-enrolled provider, Myint has provided services to 4,045 Medicare beneficiaries, totaling 11,029 services with total Medicare billing of $559,446. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 07/28/2006
- Last Updated 10/29/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184638645
Products in Payments
- XARELTO (Drug) $4,690
- INVOKANA (Drug) $1,151
- Ozempic (Drug) $821.79
- JARDIANCE (Drug) $625.84
- ELIQUIS (Drug) $483.79
- ENTRESTO (Drug) $419.47
- FARXIGA (Drug) $391.80
- BEVESPI AEROSPHERE (Drug) $331.52
- SYMBICORT (Drug) $285.99
- TRELEGY ELLIPTA (Drug) $258.34
- Kerendia (Drug) $230.55
- TRULICITY (Drug) $206.46
- LifeVest (Device) $206.01
- QVAR (Drug) $185.73
- RYBELSUS (Drug) $172.08
- JANUVIA (Drug) $150.52
- Rybelsus (Drug) $147.10
- BREO (Drug) $141.96
- BREZTRI (Drug) $141.17
- AREXVY (Drug) $124.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620